Progyny, Inc. - Common Stock (NQ:PGNY)

28.97 -0.15 (-0.52%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Spotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q4

April 03, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare...

Via StockStory

Q4 Rundown: Elevance Health (NYSE:ELV) Vs Other Health Insurance Providers Stocks

April 02, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Elevance Health (NYSE:ELV) and...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Will PROGYNY INC (NASDAQ:PGNY) Break Out? A Technical Analysis Perspective. ↗

April 01, 2025

Exploring PROGYNY INC's Technical Signals and Breakout Potential: Based on good technical signals, PROGYNY INC is potentially setting up for a breakout.

Via Chartmill

Analyst Expectations For Progyny's Future ↗

March 31, 2025

Via Benzinga

Expert Outlook: Progyny Through The Eyes Of 4 Analysts ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Breaking Down Progyny: 4 Analysts Share Their Views ↗

February 11, 2025

Via Benzinga

Progyny Expands Maternal Health Support with Addition of Doula Services

March 31, 2025

Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes

From Progyny, Inc.

Via GlobeNewswire

Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)

March 27, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Q4 Earnings Outperformers: McKesson (NYSE:MCK) And The Rest Of The Healthcare Providers & Services Stocks

March 27, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including McKesson (NYSE:MCK) and its peers.

Via StockStory

3 Stocks Under $50 in Hot Water

March 25, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks

March 25, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

James Hardie Industries, MINISO Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

March 24, 2025

Via Benzinga

Should you consider PROGYNY INC (NASDAQ:PGNY) for quality investing? ↗

March 20, 2025

A fundamental analysis of (NASDAQ:PGNY): Should Quality-Oriented Investors Explore PROGYNY INC (NASDAQ:PGNY)?

Via Chartmill

Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks

March 18, 2025

Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Unpacking Q4 Earnings: Centene (NYSE:CNC) In The Context Of Other Health Insurance Providers Stocks

March 17, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Centene (NYSE:CNC) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

March 13, 2025

Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering

March 11, 2025

The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation

From Progyny, Inc.

Via GlobeNewswire

Health Insurance Providers Stocks Q4 Highlights: Molina Healthcare (NYSE:MOH)

March 05, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Q4 Earnings Highlights: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks

March 04, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSE:UNH) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Looking for growth without the hefty price tag? Consider PROGYNY INC (NASDAQ:PGNY). ↗

March 03, 2025

NASDAQ:PGNY is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.

Via Chartmill

Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best

March 03, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Progyny Tops EPS Forecast, Eyes Growth ↗

February 28, 2025

The fertility benefits manager reported strong results for the fourth quarter.

Via The Motley Fool

These stocks are moving in today's after hours session ↗

February 27, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.7%

February 27, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.6% year on year to $298.4 million. On top of that, next quarter’s...

Via StockStory

Progyny, Inc. Announces Fourth Quarter 2024 Results

February 27, 2025

From Progyny, Inc.

Via GlobeNewswire

What To Expect From Progyny’s (PGNY) Q4 Earnings

February 26, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results tomorrow after market close. Here’s what investors should know.

Via StockStory

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report

February 13, 2025

From Progyny, Inc.

Via GlobeNewswire

NASDAQ:PGNY—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

February 12, 2025

Based on a technical and fundamental analysis of NASDAQ:PGNY we can say: PROGYNY INC (NASDAQ:PGNY), a strong growth stock, setting up for a breakout.

Via Chartmill

Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

January 28, 2025

Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning

From Progyny, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.